Correspondence| Volume 32, ISSUE 4, P379-380, August 15, 1992

Download started.


NMDA-Associated glycine binding site increases in schizophrenic brains

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Carlsson M.
        • Carlsson A.
        Schizophrenia: A subcortical neurotransmitter imbalance syndrome?.
        Schizophr Bull. 1990; 16: 425-432
        • Javitt D.C.
        • Zukin S.R.
        Recent advances in the phencyclidine model of schizophrenia.
        Am J Psychiatry. 1991; 148: 1301-1308
        • Johnson J.W.
        • Ascher P.
        Glycine potentiates the NMDA response in cultured mouse brain neurons.
        Nature. 1987; 325: 529-531
        • Kim J.S.
        • Kornhuber H.H.
        • Schmid-Burgk W.
        • et al.
        Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia.
        Neurosci Lett. 1980; 20: 379-382
        • Kleckner N.W.
        • Dingledine R.
        Requirement for glycine in inactivation of NMDA-receptors expressed in Xenopus oocytes.
        Science. 1988; 241: 835-837
        • Kornhuber J.
        • Kornhuber M.E.
        Presynaptic dopaminergic modulation of cortical input to the striatum.
        Life Sci. 1986; 39: 669-674
        • Kornhuber J.
        • Mack-Burkhardt F.
        • Riedere P.
        • et al.
        [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients.
        J Neural Transm. 1989; 77: 231-236
        • Nishikawa T.
        • Takashima M.
        • Toru M.
        Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia.
        Neurosci Lett. 1983; 40: 245-250
        • Ogita K.
        • Suzuki T.
        • Yoneda Y.
        Strychnine-insensitive binding of [3H]glycine to synaptic membranes in rat brain, treated with Triton X-100.
        Neuropharmacology. 1989; 28: 1263-1270
        • Toru M.
        • Takashima M.
        • Mataga N.
        • et al.
        Hyperdopaminergic and hypoglutamatergic states in postmortem schizophrenic brain.
        Schizophrenia: An Integrative View. 1984; (abs.): 85
        • Toru M.
        • Watanabe S.
        • Shibuya H.
        • et al.
        Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.
        Acta Psychiatr Scand. 1988; 78: 121-137
        • Utas J.
        • Monaghan D.T.
        • Cotman C.W.
        Plastic responses of hippocampal excitatory amino acid receptors to deafferent and reinnervation.
        Neuroscience. 1990; 34: 9-17
        • Utas J.
        • Monaghan D.T.
        • Cotman C.W.
        Kainate receptors in the rat hippocampus: A distribution and time course of changes in response to unilateral lesions of the entorhinal cortex.
        J Neurosci. 1990; 10: 2352-2362